Daré Bioscience, Inc.
DARENASDAQHealthcare● Active
$1.85
$-0.03(-1.60%)
Market Cap$17615082
P/E Ratio—
52W High$9.19
52W Low$1.27
Daré Bioscience, Inc.（DARE）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · DARE · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.03M | $0.01M | $2.81M | $10.00M | $0.00M |
| Cost of Revenue | $2.45M | $14.31M | $21.64M | $30.14M | $0.10M |
| Gross Profit | ($1.42M) | ($14.30M) | ($18.83M) | ($20.14M) | ($0.10M) |
| Gross Margin %(computed) | -137.55% | — | -670.62% | -201.42% | — |
| Operating Expenses | |||||
| R&D Expenses | $5523.35M | $14.21M | $21.54M | $30.04M | $30.62M |
| G&A Expenses | $8.76M | $8.36M | $11.31M | $10.64M | $7.79M |
| Total Operating Expenses | $12.14M | $9.16M | $12.11M | $11.24M | $38.97M |
| Operating Income | ($13.55M) | ($23.45M) | ($30.94M) | ($31.39M) | ($39.07M) |
| Operating Margin %(computed) | — | — | — | -313.85% | — |
| Interest Income | $0.68M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.82M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($13.40M) | ($4.05M) | ($30.16M) | ($30.95M) | ($38.70M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($13.40M) | ($4.05M) | ($30.16M) | ($30.95M) | ($38.70M) |
| Net Margin %(computed) | — | — | — | -309.48% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.20 | $-0.48 | $-4.15 | $-4.39 | $-7.52 |
| Wtd Avg Shares | 111.79M | 8.50M | 7.28M | 7.05M | 5.10M |
| EBITDA | ($11.40M) | ($23.41M) | ($30.70M) | ($31.36M) | ($39.04M) |
| EBITDA Margin %(computed) | — | — | — | -313.61% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Daré Bioscience, Inc.
关于Daré Bioscience, Inc.（DARE）损益表
Daré Bioscience, Inc.（DARE）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，DARE实现营收$0.00B，毛利润($0.00B)（毛利率-137.55%），净利润($0.01B)（净利率-1300.66%）。
常见问题
DARE · 4 问Daré Bioscience, Inc.（DARE）2025财年营收为$0.00B，同比up10429.4%。
DARE revenueDARE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09